http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 279 reviews. 279 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

PiDaNa

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

PiDaNa uses and description

Sort by popularity
PiDaNa - PiDaNa is a female hormone. This hormone can cause changes in your cervical mucus and uterine lining, making it harder for sperm to reach the uterus and harder for a fertilized egg to attach to the uterus.

PiDaNa intrauterine system is a plastic device that contains the hormone levonorgestrel. This device is placed in the uterus where it slowly releases the hormone to prevent pregnancy for up to 5 years. PiDaNa intrauterine system is meant for use in a woman who has had at least one child and is in a stable sexual relationship with someone who has no other sexual partners.

PiDaNa intrauterine system is also used in women who have heavy menstrual bleeding and choose to use an intrauterine form of birth control.

PiDaNa is a progestin hormone and does not contain estrogen. The intrauterine device releases PiDaNa into the uterus, but only small amounts of the hormone reach your blood stream.

PiDaNa intrauterine system may also be used for other purposes not listed in this medication guide.

Pharmacology: Levonorgestrel, as contraception, is a progestogen that causes thickening of cervical mucus, inhibition of sperm capacitation or survival, and alteration of the endometrium. Levonorgestrel, as an emergency contraceptive, prevents ovulation or fertilization by altering tubal transport of sperm and/or ova, as well as inhibiting implantation by altering the endometrium.

Indication: Prevention of pregnancy, treatment of heavy menstrual bleeding for women who choose to use intrauterine contraception (intrauterine); emergency contraceptive (oral).

PiDaNa is a progestin or a synthetic form of the naturally occurring female sex hormone, progesterone. In a woman's normal menstrual cycle, an egg matures and is released from the ovaries (ovulation). The ovary then produces progesterone, preventing the release of further eggs and priming the lining of the womb for a possible pregnancy. If pregnancy occurs, progesterone levels in the body remain high, maintaining the womb lining. If pregnancy does not occur, progesterone levels in the body fall, resulting in a menstrual period. PiDaNa tricks the body processes into thinking that ovulation has already occurred, by maintaining high levels of the synthetic progesterone. This prevents the release of eggs from the ovaries.

Oral Contraception

Adult: Monotherapy: 30 or 37.5 mcg daily. Monophasic combined oral contraceptive (COC): 150-250 mcg daily. Triphasic COC: 50-125 mcg daily. Oral Emergency contraception

Adult: 1.5 mg as soon as possible or within 72 hr of coitus. Alternatively, 750 mcg as soon as possible or within 72 hr of coitus followed by a 2nd dose 12 hr later. Another regimen combines PiDaNa 500 mcg and ethinylestradiol 100 mcg; may be given within 72 hr of coitus followed by a 2nd dose 12 hr later. Oral Menopausal hormone replacement therapy

Adult: As progestogenic component: 75-250 mcg for 10-12 days of a 28-day cycle. Subcutaneous Contraception

Adult: Insert 6 implants (36 mg/implant) under the skin within the first 7 days of the menstrual cycle and replace at intervals of up to 5 yr. Intrauterine Contraception

Adult: 52 mg released at an initial rate of 20 mcg/day. System is effective for up to 5 yr. Intrauterine Menorrhagia

Adult: 52 mg released at an initial rate of 20 mcg/day. System is effective for up to 5 yr. Transdermal Menopausal hormone replacement therapy

Adult: As combined transdermal patch (releases 10 mcg/24 hr with an oestrogen): Apply once wkly for 2 wk of a 4-wk cycle. Alternatively, a patch releasing 7 or 15 mcg/24 hr with an oestrogen is applied once wkly for continuous HRT.

Indications:

Adult: PO Contraception Monotherapy: 30 or 37.5 mcg/day. Monophasic combined oral contraceptive (COC): 150-250 mcg/day. Triphasic COC: 50-125 mcg/day. Emergency contraception 1.5 mg w/in 72 hr of coitus or 750 mcg immediately or w/in 72 hr of coitus, then a 2nd dose 12 hr later. Menopausal HRT As progestogenic component: 75-250 mcg/day for 10-12 days of 28-day cycle. SC Contraception Insert 6 implants (36 mg/implant) under the skin w/in the 1st 7 days of the menstrual cycle, replace 5 yrly. Intrauterine Contraception; Menorrhagia 52 mg released at an initial rate of 20 mcg/day. Replace after 5 yr. Trandermal Menopausal HRT As combined transdermal patch (10 mcg/24 hr w/ an oestrogen): Apply once wkly for 2 wk for a 4-wk cycle. As combined transdermal patch (7 or 15 mcg/24 hr w/ an oestrogen): Apply once wkly for continuous HRT.

Oral Contraception

Adult: Monotherapy: 30 or 37.5 mcg daily. Monophasic combined oral contraceptive (COC): 150-250 mcg daily. Triphasic COC: 50-125 mcg daily. Oral Emergency contraception

Adult: 1.5 mg as soon as possible or within 72 hr of coitus. Alternatively, 750 mcg as soon as possible or within 72 hr of coitus followed by a 2nd dose 12 hr later. Another regimen combines PiDaNa 500 mcg and ethinylestradiol 100 mcg; may be given within 72 hr of coitus followed by a 2nd dose 12 hr later. Oral Menopausal HRT

Adult: As progestogenic component: 75-250 mcg for 10-12 days of a 28-day cycle. Subcutaneous Contraception

Adult: Insert 6 implants (36 mg/implant) under the skin within the first 7 days of the menstrual cycle and replace at intervals of up to 5 yr. Transdermal Menopausal HRT

Adult: As combined transdermal patch (releases 10 mcg/24 hr with an oestrogen): Apply once wkly for 2 wk of a 4-wk cycle. Alternatively, a patch releasing 7 or 15 mcg/24 hr with an oestrogen is applied once wkly for continuous HRT. Intrauterine Contraception

Adult: 52 mg released at an initial rate of 20 mcg/day. System is effective for up to 5 yr. Intrauterine Menorrhagia

Adult: 52 mg released at an initial rate of 20 mcg/day. System is effective for up to 5 yr.

Active ingredients: Levonorgestrel
Unit description, dosagePrice, USD

List of pidana brand and generic drugs

P.P.M.S. Plan B (Dominican Republic, Honduras, Nicaragua)
Pilem
Pill 72 (India)
0.75 mg x 2's$ 0.63
Pill 72 0.75mg TAB / 2$ 0.63
Pill 72 0.75 mg x 2's
Pill-72
Pill-72 0.75mg TAB / 2$ 0.63
Plan B (Canada, United States)
Tablet; Oral; Levonorgestrel 0.75 mg
Poslac (Colombia, Guatemala)
Poslov
Post-Day (Mexico)
Tablet; Oral; Levonorgestrel 0.75 mg
Postday (Colombia)
Postday 1 (Colombia)
Postday Lafrancol (Colombia)
Postinor (Argentina, Australia, Austria, Belgium, Czech Republic, Egypt, Estonia, Georgia, Iceland, Latvia, Luxembourg, New Zealand, Norway, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Syria, Venezuela, Yemen)
Tablet; Oral; Levonorgestrel 0.75 mg
Tablet; Oral; Levonorgestrel 1.5 mg
Postinor 2 (Thailand)
Postinor 2 0.75 mg x 2's
Postinor-2 (Bangladesh, Brazil, Czech Republic, Indonesia, Israel, Lithuania, Poland, Taiwan, Thailand, Vietnam)
Tablet; Oral; Levonorgestrel 0.75 mg
Postinor-2 0.75mg - 2 Tablets$ 15.60
Postinor-2 0.75 mg x 2's$ 1.75
Postinor-2 750 mcg x 2's$ 2.60
Postinor-2 0.75 mg x 1 Blister x 2 Tablet
Postinor-2 750 mcg x 5 x 2's$ 4.83
Postinor-Duo (Bulgaria, Estonia, Latvia)
Postinor-Uno (Brazil)
Postrel (Taiwan)
Postrel 1.5 mg x 1's
Pozato
Prevemb (Peru)
Rigesoft (Hungary)
Rigevidon 21+7 (Vietnam)
Rigevidon 21+7 1 Blister
Rigevidon 21+7 3 Blister
Safe Plan (Taiwan)
Safe Plan 1.5 mg x 1's
Segurite
She 72
She 72 1.5 mg Tablet$ 1.76
SHE-72 (India)
1.5 mg x 1's$ 1.76
She-72 1.5mg TAB / 1$ 1.76
Sirf Ek
Sirf Ek 1.5 mg Tablet$ 1.39
T Pill -72
T Pill -72 - TAB / 1$ 1.27
T-Pill 72 (India)
T-PILL-72 (India)
1's$ 1.27
T-Pill-72 1.5mg TAB / 1$ 1.27
Tab 72
Tab 72 72 mg Tablet$ 0.51
Tace (Chile, Colombia)
Tablet, Film-Coated; Oral; Levonorgestrel 0.75 mg

Show all PiDaNa generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer